Erschienen in:
01.02.2014 | Capsule Commentary
Capsule Commentary on Turner et al., Chronic Opioid Therapy Risk Reduction Initiative: Impact on Urine Drug Testing Rates and Results
verfasst von:
Ben A. Rich, JD, PhD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 2/2014
Einloggen, um Zugang zu erhalten
Excerpt
This study assessed the impact of a multi-faceted risk reduction initiative for patients on opioid therapy.
1 It focused on urine drug screening (UDS), and noted that although the initiative increased UDS (from 7 to 50 %), that rate was well below the initiative’s target. Moreover, there was no commensurate impact on the rate of abnormalities identified, such as marijuana or illicit drugs. …